Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial - Judson, Ian; Hohenberger, Peter (The lancet. Oncology, 2014)
Gesehen am: 24.11.2016